Halberd’s CEO on The Stock Day Podcast Breaking Down 20X Neutralizing Affinity SARS-COV-2 Antibody

The Stock Day Podcast welcomed Halberd Corporation (OTC PINK:HALB)(“the Company”), a company that holds the exclusive rights to the patented extracorporeal treatment technology and the provisional patent applications associated with Covid-19. CEO and Chairman  of the Company, William A Hartman, joined Stock Day host Everett Jolly.